Results 51 to 60 of about 473,693 (291)

Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice. [PDF]

open access: yesPLoS ONE, 2017
In an effort to make affordable vaccines suitable for the regions most affected by HIV-1, we have constructed stable vaccines that express an HIV-1 subtype C mosaic Gag immunogen (BCG-GagM, MVA-GagM and DNA-GagM).
Ros Chapman   +4 more
doaj   +1 more source

Protectivity of COVID-19 Vaccines and Its Relationship with Humoral Immune Response and Vaccination Strategy: A One-Year Cohort Study

open access: yesVaccines, 2022
This prospective cohort study aimed to evaluate the efficacy of COVID-19 vaccine schemes, homologous versus heterologous vaccine strategies, and vaccine-induced anti-S-RBD-IgG antibody response in preventing COVID-19 among 942 healthcare workers 1 year ...
Ferdi Tanir   +8 more
doaj   +1 more source

Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers

open access: yes, 2022
We investigated here the response of anti-SARS-CoV-2 IgA antibodies to BNT162b2 primary vaccination followed by administration of a homologous booster dose in baseline seronegative healthcare ...
Lippi Giuseppe   +4 more
core   +1 more source

Leukocytic and Pyrogenic Effects of Typhoid Vaccine and Augmentation by Homologous Plasma

open access: yesExperimental Biology and Medicine, 1950
Summary and ConclusionsThe effects of intravenously administered typhoid vaccine upon the leukocyte population and the temperature of the rabbit were studied.The response of the temperature and of the leukocyte count was dependent upon the amount of typhoid vaccine given.
R S, FARR, V S, LeQUIRE
openaire   +2 more sources

Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. [PDF]

open access: yes, 2007
Mycobacterium bovis BCG is widely used as a vaccine against tuberculosis (TB), despite its variable protective efficacy. Relatively little is known about the immune response profiles following BCG vaccination in relation to protection against TB. Here we
Klein, Michèl R   +12 more
core   +1 more source

Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients

open access: yesFrontiers in Immunology, 2023
Due to rare but major adverse reactions to the AstraZeneca adenoviral ChAdOx1-S-nCoV-19 vaccine (ChAd), German health authorities recommended adults under 60 who received one dose of ChAd, to receive a second dose of the BioNTech mRNA BNT162b2 vaccine ...
Chang Chu   +18 more
doaj   +1 more source

Immunotherapy of Tumors with Protein Vaccine Based on Chicken Homologous Tie-2 [PDF]

open access: yesClinical Cancer Research, 2006
AbstractPurpose: Tie-2 is an endothelium-specific receptor tyrosine kinase known to play a key role in tumor angiogenesis. The present study explores the feasibility of immunotherapy of tumors by using a protein vaccine based on chicken Tie-2 as a model antigen to break the immune tolerance against Tie-2 in a cross-reaction between the xenogeneic ...
Yan, Luo   +14 more
openaire   +2 more sources

Immunogenicity and Effectiveness of Primary and Booster Vaccine Combination Strategies during Periods of SARS-CoV-2 Delta and Omicron Variants

open access: yesVaccines, 2022
In this study involving a cohort of employees of the National Airline company in Lebanon, we assessed humoral immunity levels and the effectiveness of two COVID-19 vaccines, Gam-COVID-Vac versus BNT162b2, after two doses and after a homologous and ...
Rima Moghnieh   +5 more
doaj   +1 more source

Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2

open access: yesVaccines, 2022
Background: Due to findings on adverse reactions and clinical efficacy of different vaccinations against SARS-CoV-2, the administration of vaccination regimens containing both adenoviral vector vaccines and mRNA-based vaccines has become common. Data are
Robert Daniel Heinrich Markewitz   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy